REQUEST A DEMO
Total
USD $0.00
Search more companies

Keymed Biosciences Inc. (Hong Kong) (Hong Kong SAR, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Keymed Biosciences Inc. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Keymed Biosciences Inc. is a limited liability company established by Zhongtian Decoration. The company was approved by the Zhongtian Decoration shareholders' meeting on October 20, 2013, and the founding meeting of the joint-stock company on November 8, 2013. The company's net assets, as audited by Deloitte Touche Tohmatsu Certified Public Accountants, were 135,184,171.72 yuan as of May 31, 2013. Based on this, the company's capital was converted into 108 million shares with a face value of 1.00 yuan per share, at a conversion ratio of 80%. The remaining 27,184,171.72 yuan was included in capital reserves. The company changed its name to Shenzhen Zhongtian Fine Decoration Co., Ltd. on November 8, 2013. On November 11, 2013, Zhongtian Decoration completed the business registration procedures at the Shenzhen Market Supervision Administration and obtained the enterprise legal person business license with registration number 440301104099082 and a registered capital of 108 million yuan.

Headquarters
18 Biotown Middle Road Building D2, Chengdu Tianfu International Biotown, 610219
Chengdu; Sichuan;

Contact Details: Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.

Website: http://www.keymedbio.com

Basic Information
Total Employees:
Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.
Registered Capital:
Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.
Financial Auditors:
Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.
Incorporation Date:
April 23, 2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Senior Vice President
Purchase this report to view the information.
Senior Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
27.86%
Purchase this report to view the information.
9.26%
Purchase this report to view the information.
5.85%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Beijing Lingyue Biomedical Technology Co., Ltd (China)
100%
Chengdu Huamian Biotechnology Co., Ltd. (China)
100%
Kangnuo Boyu Biomedical Technology (Chengdu) Co.,Ltd. (China)
100%
Company Performance
Financial values in the chart are available after Keymed Biosciences Inc. (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
227.12%
Total operating revenue
231.82%
Operating profit (EBIT)
N/A
EBITDA
-59.76%
Net Profit (Loss) for the Period
1807.49%
Total assets
-0.87%
Total equity
-7.11%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
12.2%
Return on Equity (ROE)
1.36%
Debt to Equity Ratio
5.69%
Quick Ratio
3.27%
Cash Ratio
-4.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?